IFLR1000

News and features

Articles

Article type
Practice area

Showing 11 - 20 of 108

News & Analysis

How to Process the Forward Looking Statements as per the Communiqué on Material Events?

04 December 2019 by Gönenç Gürkaynak, Esq., Damla Doğancalı and Selen Sakar

BRIEFING: Istanbul, 4 December, 2019
News & Analysis

European Union Initiates Dispute Complaint Against Turkey’s Measures on Imports of Pharmaceutical Products

05 November 2019 by Gönenç Gürkaynak, Esq., Ceren Yıldız, Sinem Uğur, Nazlı Gürün

BRIEFING: Istanbul, 5 November, 2019
News & Analysis

In Online Marketplace Sales, Courts Rule with an Eye towards the Parties of Sales Transactions

25 October 2019 by Gönenç Gürkaynak, Esq., Tolga Uluay, Doruk Altın and Safa Koyuncu

BRIEFING: Istanbul, 25 October, 2019
News & Analysis

Intercompany Loans under the Capital Movements Circular

10 September 2019 by Gönenç Gürkaynak, Esq., Damla Doğancalı and Büşra Üstüntaş

BRIEFING: Istanbul, 10 September, 2019
News & Analysis

Prof. Dr. H. Ercüment Erdem has been appointed as Chair of ICC CLP Commission

04 July 2019 by Erdem & Erdem - Turkey

PRESS RELEASE: Istanbul, 2 July, 2019

News & Analysis

Investigations Concluded Without Applying Any Anti-Dumping Duties: Precedents of the Ministry of Trade

16 May 2019 by Gönenç Gürkaynak, Esq., Ceren Yildiz, Sinem Uğur and Nazli Gürün

BRIEFING: Istanbul, 16 May 2019

News & Analysis

The New Dispute Resolution Method for Commercial Disputes: Mandatory Mediation

10 April 2019 by Gönenç Gürkaynak, Esq., Ceyda Karaoğlan Nalçacı, Berat Ataseven and Cansu Kavan

BRIEFING: Istanbul, 10 April, 2019
News & Analysis

Squeeze-Out Right in Group of Companies

06 March 2019 by Gönenç Gürkaynak, Esq., Nazlı Nil Yukaruç, Damla Doğancalı and Ece İlci

BRIEFING: Istanbul, 6 March, 2019
News & Analysis

2019 M&A Report: Turkey

01 March 2019 by Ercüment Erdem and Özgür Kocabaşoğlu, Erdem & Erdem Law Office

The Annual Turkish M&A Review 2018 by Ernst & Young reports that somewhere around 191 transactions were closed in 2018, with a total value of $9.3 billion.
News & Analysis

An Overview of Corruption Risks in the Pharmaceutical Sector

06 February 2019 by Gönenç Gürkaynak, Esq., Ceren Yıldız and Nazlı Gürün

BRIEFING: Istanbul, 6 February , 2019

Load more